BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 7769190)

  • 21. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB; Stathopoulos G
    Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
    Nakshabendi IM; Duncan A; Russell RI
    Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory bowel disease.
    Hanauer SB
    N Engl J Med; 1996 Mar; 334(13):841-8. PubMed ID: 8596552
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
    Sutherland LR
    CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical therapy for ulcerative colitis in childhood.
    Ament ME; Vargas JH
    Semin Pediatr Surg; 1994 Feb; 3(1):28-32. PubMed ID: 7914811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease].
    Hinojosa J; Molés JR; Nos P; Hoyos M; Ramírez JJ; Primo J; Fernández J; Berenguer J
    Rev Esp Enferm Dig; 1995 Nov; 87(11):775-80. PubMed ID: 8534531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current medical therapy for inflammatory bowel disease.
    Bonner GF
    South Med J; 1996 Jun; 89(6):556-66. PubMed ID: 8638193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
    Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical management of severe inflammatory disease of the rectum and distal colon: non-nutritional aspects.
    Polson RJ; Misiewicz JJ
    Baillieres Clin Gastroenterol; 1992 Mar; 6(1):1-26. PubMed ID: 1586763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A; Halter F
    Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's disease.
    Zimmerman MJ; Jewell DP
    Aliment Pharmacol Ther; 1996; 10 Suppl 2():93-8; discussion 99. PubMed ID: 8899107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional medical management of inflammatory bowel disease.
    Burger D; Travis S
    Gastroenterology; 2011 May; 140(6):1827-1837.e2. PubMed ID: 21530749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.
    Martin F
    Dig Dis Sci; 1987 Dec; 32(12 Suppl):57S-63S. PubMed ID: 2891469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newer pharmacologic agents for the therapy of inflammatory bowel disease.
    Ruderman WB
    Med Clin North Am; 1990 Jan; 74(1):133-53. PubMed ID: 2404172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroids for the management of ulcerative colitis and Crohn's disease.
    Jewell DP
    Gastroenterol Clin North Am; 1989 Mar; 18(1):21-34. PubMed ID: 2646220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminosalicylates.
    Campregher C; Gasche C
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):535-46. PubMed ID: 22122769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic efficacy of 5-ASA molecules in idiopathic intestinal inflammatory diseases: critical review].
    Van Gossum A
    Acta Gastroenterol Belg; 1992; 55(5-6):462-71. PubMed ID: 1363167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of inflammatory bowel disease in adults.
    Katz JA
    J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional treatment of Crohn's disease: objectives and outcomes.
    Rutgeerts PJ
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S2-8. PubMed ID: 11380039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.